爵士制药 JAZZ 深 沪
交易中 08-10 10:19:34 美东时间
260.25
+3.690
+1.44%
华盛通- 最 高265.045
- 今 开256.95
- 成交量 16.61万股
- 最 低 247.42
- 昨 收 256.56
- 总市值 1625.07万
- 52周最高 265.045
- 市盈率 静 --
- 换手率 265.94%
- 52周最低 117.10
- 委 比 96.64%
- 总股本 6.24万
- 历史最高 265.045
- 量 比 2.18
- 振 幅 6.87%
- 历史最低 1.10
- 每 手 1
- 风险率 41.74%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Jazz Pharmaceuticals Gains Oncology Firepower Through AbCellera Collaboration
Jazz Pharmaceuticals teams with AbCellera on cancer therapies as analysts maintain positive targets despite a recent Zepzelca trial setback.
06-18 00:54
Jazz Pharmaceuticals' New Cancer Drug Drives $1.3 Billion Opportunity, Says Analyst
Jazz Pharma (JAZZ) revenue growth driven by Ziihera adoption as 1L treatment for HER2+ GEA, says BofA analyst.
06-11 00:44
Jazz Pharmaceuticals To Present 21 Abstracts At SLEEP
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) today announced that the company will present 21 abstracts, including 11 late-breaking abstracts, at SLEEP 2026, the 40th annual meeting of the Associated Professional Sleep
06-04 19:50
Earnings Summary: Jazz Pharmaceuticals Q4
The Q4 earnings report for Jazz Pharmaceuticals (NASDAQ:JAZZ) was released on T...
02-25 05:08
Needham Maintains Buy on Jazz Pharmaceuticals, Raises Price Target to $235
Needham analyst Ami Fadia maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and raises the price target from $210 to $235.
01-12 17:46
晚报| 美批准英伟达向中国销售芯片！AI产业链全线爆发！中央城市工作会议：加快构建房地产发展新模式！7月15日影响重磅消息汇总
（来源：京城夜读） 收盘总结 创业板指放量大涨1.73%、沪指险守3500点！两市下跌个股超4000只 AI产业链全线爆发。三大指数全天表现分化，收盘涨跌不一...
2025-07-15 19:43
DraftKings To Rally Over 29%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a comple...
2025-03-11 00:16
Cantor Fitzgerald Reiterates Overweight on Jazz Pharmaceuticals, Maintains $140 Price Target
Cantor Fitzgerald analyst Charles Duncan reiterates Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Overweight and maintains $140 price target.
2024-09-09 23:43
Jazz Pharmaceuticals Highlights Zanidatamab and Zepzelca Cancer Trials at ESMO Congress
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) today announced that the Company, along with its partners, will present five abstracts at the European Society for Medical Oncology (ESMO) Congress 2024 from September 13-17, 2024,
2024-09-09 20:00
